<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02332629</url>
  </required_header>
  <id_info>
    <org_study_id>HK_VL_08_2014a</org_study_id>
    <nct_id>NCT02332629</nct_id>
  </id_info>
  <brief_title>Effect of Methylprednisolone on Endothelial Function in Patients Undergoing Total Knee-arthroplasty</brief_title>
  <official_title>Effect of Preoperative Intravenous High Dose Methylprednisolone on Endothelial Function in Patients Scheduled for Total Knee-arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the pathophysiological effects of a single dose methylprednisolone
      administered prior to total knee-arthroplasty surgery (TKA). The investigators examine the
      effect on the endothelial glycocalyx shedding due to surgical trauma.

      Half of participants will receive intravenous Solu-Medrol 125 mg, while the other half will
      receive placebo.

      The investigators hypothesize that the group receiving methylprednisolone will experience
      reduction in glycocalyx degradation compared to the placebo-group, early after TKA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The anti-inflammatory effects of glucocorticoids are well known. The beneficial effects on
      postoperative pain, postoperative nausea and vomiting are well-documented.

      Postoperatively, activation and / or dysregulation of the inflammatory system influence on
      the endothelial glycocalyx. Damage of the vascular endothelia increases the risk of
      cardiovascular and thromboembolic complications.

      In animal studies glucocorticoids have been found to preserve the endothelial glycocalyx and
      the vascular barrier.

      The effect of glucocorticoids on human endothelial glycocalyx after surgery is unknown and
      calls for further investigation.

      This study is embedded in a primary study registrated as: NCT02319343

      For further details please view the EudraCT registration:

      EudraCT nr.: 2014-003395-23
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in plasma Syndecan-1 from baseline (before surgery) to 24 hours after surgery</measure>
    <time_frame>baseline to 24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in plasma soluble Thrombomodulin from baseline (before surgery) to 24 hours after surgery</measure>
    <time_frame>baseline to 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in plasma SE-Selectin from baseline (before surgery) to 24 hours after surgery</measure>
    <time_frame>One day after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in plasma VE-Cadherin from baseline (before surgery) to 24 hours after surgery</measure>
    <time_frame>baseline to 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Osteoarthrosis</condition>
  <arm_group>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preoperative single high dose of Solu-Medrol 125 mg iv.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isotonic Sodium Chloride</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Preoperative single dose of isotonic Sodium Chloride</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone</intervention_name>
    <description>Comparison of preoperative single high dose of Methylprednisolone 125 mg iv. and isotonic Sodium Chloride</description>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <other_name>Solu-Medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isotonic Sodium Chloride</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Isotonic Sodium Chloride</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Osteoarthrosis

          -  Undergoing total unilateral knee-arthroplasty surgery

          -  Speak and understand Danish

          -  Have given informed consent

        Exclusion Criteria:

          -  Revision, bilateral og uni chamber knee-arthroplasty surgery

          -  General anaesthesia

          -  Allergy or intolerance towards Methylprednisolone

          -  Local or systemic infection

          -  Permanent systemic treatment with steroids within 30 days preoperatively

          -  Insulin-dependent diabetes

          -  Active treatment of ulcer within 3 months preoperatively

          -  Cancer disease

          -  Autoimmune disease incl. rheumatoid arthritis

          -  Pregnant or breast feeding women

          -  Menopause &lt;1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Viktoria Lindberg-Larsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Section for Surgical Pathophysiology, Rigshospitalet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen NV</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Husted H. Fast-track hip and knee arthroplasty: clinical and organizational aspects. Acta Orthop Suppl. 2012 Oct;83(346):1-39. doi: 10.3109/17453674.2012.700593. Review.</citation>
    <PMID>23205862</PMID>
  </reference>
  <reference>
    <citation>Kehlet H. Fast-track hip and knee arthroplasty. Lancet. 2013 May 11;381(9878):1600-2. doi: 10.1016/S0140-6736(13)61003-X.</citation>
    <PMID>23663938</PMID>
  </reference>
  <reference>
    <citation>Khan SK, Malviya A, Muller SD, Carluke I, Partington PF, Emmerson KP, Reed MR. Reduced short-term complications and mortality following Enhanced Recovery primary hip and knee arthroplasty: results from 6,000 consecutive procedures. Acta Orthop. 2014 Feb;85(1):26-31. doi: 10.3109/17453674.2013.874925. Epub 2013 Dec 20.</citation>
    <PMID>24359028</PMID>
  </reference>
  <reference>
    <citation>Malviya A, Martin K, Harper I, Muller SD, Emmerson KP, Partington PF, Reed MR. Enhanced recovery program for hip and knee replacement reduces death rate. Acta Orthop. 2011 Oct;82(5):577-81. doi: 10.3109/17453674.2011.618911. Epub 2011 Sep 6.</citation>
    <PMID>21895500</PMID>
  </reference>
  <reference>
    <citation>Ostrowski SR, Johansson PI. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy. J Trauma Acute Care Surg. 2012 Jul;73(1):60-6. doi: 10.1097/TA.0b013e31825b5c10.</citation>
    <PMID>22743373</PMID>
  </reference>
  <reference>
    <citation>Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011 Aug;254(2):194-200. doi: 10.1097/SLA.0b013e318226113d.</citation>
    <PMID>21772125</PMID>
  </reference>
  <reference>
    <citation>Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, Chappell D, Stoeckelhuber M, Welsch U, Reichart B, Peter K, Becker BF. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007 Oct 23;116(17):1896-906. Epub 2007 Oct 8.</citation>
    <PMID>17923576</PMID>
  </reference>
  <reference>
    <citation>Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth. 2012 Mar;108(3):384-94. doi: 10.1093/bja/aer515. Epub 2012 Jan 29. Review.</citation>
    <PMID>22290457</PMID>
  </reference>
  <reference>
    <citation>Chappell D, Jacob M, Hofmann-Kiefer K, Bruegger D, Rehm M, Conzen P, Welsch U, Becker BF. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology. 2007 Nov;107(5):776-84.</citation>
    <PMID>18073553</PMID>
  </reference>
  <reference>
    <citation>Chappell D, Hofmann-Kiefer K, Jacob M, Rehm M, Briegel J, Welsch U, Conzen P, Becker BF. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol. 2009 Jan;104(1):78-89. doi: 10.1007/s00395-008-0749-5. Epub 2008 Oct 3.</citation>
    <PMID>18836678</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2015</study_first_submitted>
  <study_first_submitted_qc>January 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2015</study_first_posted>
  <last_update_submitted>April 7, 2016</last_update_submitted>
  <last_update_submitted_qc>April 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Viktoria Oline Lindberg-Larsen</investigator_full_name>
    <investigator_title>MD, research assistant</investigator_title>
  </responsible_party>
  <keyword>Glucocorticoid</keyword>
  <keyword>Endothelial barrier</keyword>
  <keyword>Glycocalyx</keyword>
  <keyword>Knee arthroplasty, total</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

